The level of bioavailable growth hormone (GH) after the first GH injection predicts the first year's growth response in GH-deficient children

Journal of Endocrinological Investigation

Volumn 22, Issue 10, 1999, Pages 790-795

  Bozzola, Mauro ^a   Radetti, G ^b   Pagani, S ^a   Draghi, M ^a   Aimaretti, G ^c   Rondini, G ^a  

^a UNIVERSITY OF PAVIA   (Italy)

^b Ospedale Regionale   (Italy)

^c MOLINETTE HOSPITAL   (Italy)

Author keywords

Bioassay; GH therapy; Immunoassay; Pharmacokinetics

Indexed keywords

HUMAN GROWTH HORMONE;

ARTICLE; CLINICAL ARTICLE; DOSE RESPONSE; FEMALE; GROWTH HORMONE BLOOD LEVEL; GROWTH HORMONE DEFICIENCY; HUMAN; IMMUNOFLUORESCENCE TEST; MALE; PHARMACOKINETICS; SCHOOL CHILD; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0032749283     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03343645     Document Type: Article

References (26)

1. Drug and Therapeutics Committee of the Lawson Wilkins Pediatric Endocrine Society. Guidelines for the use of growth hormone in children with short stature. J. Pediatr. 1995, 127: 857-867.
2. Fraiser S.D., Costin G., Lippe B.M., Aceto T., Bunger P.F. A dose-response curve for human growth hormone. J. Clin. Endocrinol. Metab. 1981, 53: 1213-1217.
3. Frasier S.D. Human pituitary growth hormone (hGH) therapy in growth hormone deficiency. Endocr. Rev. 1983, 4: 155-170.
4. Preece M.A., Tanner J.M., Whitehouse R.H., Cameron N. Dose dependence of growth response to human growth hormone in growth hormone deficiency. J. Clin. Endocrinol. Metab. 1976, 42: 477-483.
5. Ranke M., Weber B., Biench J.R. Long-term response to human growth hormone in 36 children with idiopathic growth hormone deficiency. Eur. J. Pediatr. 1979, 132: 221-238.
6. Job J.C., Chaussain J.L., Gamier P., Rolland A., Joab N. Dose-response relationship in the treatment of hypopituitary children with human growth hormone: a retrospective survey. Acta Paediatr. Scand. 1987, 337 (Suppl.): 93-105.
7. Kastrup K.W., Christiansen S.J., Andersen K.J., Onskov H. Increased growth rate following transfer to daily subcutaneous administration from three weekly intramuscular injections of hGH in growth hormone deficient children. Acta Endocrinol. 1983, 104: 148-152.
8. Greulich W., Pyle S.I. Radiographic Atlas of Skeletal Development of the Hand and Wrist, ed. 2. Stanford University Press, Palo Alto, 1959.
9. Albertsson-Wikland K., jansson C., Rosberg S., Novamo A. Time-resolved immunofluorometric assay of human growth hormone. Clin. Chem. 1993, 39: 1620-1625.
10. Rott A.W., Duckett G.E., Geiszler J.E., Hu C.S., Bercu B.B. Evaluation of the clinical utility of the ultrasensitive immunofluorometric assay for growth hormone (GH) and of the cortisol secretory pattern in prediction of the linear growth response to treatment with GH. J. Pediatr. Endocrinol. Metab. 1997, 13: 3-10.
11. Tanaka T., Shiu R.P.C., Gout P.W., Beer C.T., Noble R.L., Friesen H.G. A new sensitive and specific bioassay for lactogenic hormones: measurement of prolactin and growth hormone in human serum. J. Clin. Endocrinol. Metab. 1980, 51: 1058-1063.
12. 2 node lymphoma cells. Endocrinology 1987, 120: 2389-2397.
13. 2 cell bioassay in children with growth disorders. J. Endocrinol. Invest. 1998, 21: 765-770.
14. Hintz R.L., Rosenfeld R.G., Wilson D.M., Bennet A., Finno J., McClellan B., Swify R. Biosynthetic methionyl human growth hormone is biologically active in adult man. Lancet 1982, i: 276-279.
15. Takano K., Hizuka N., Shizume K., Asakawa K., Kogawa M. Short-term study of biosynthesised hGH in man. Endocrinol. Jpn. 1983, 30: 79-84.
16. Takano K., Shizume K. Current clinical trials with authentic recombinant human growth hormone in Japan. Acta Paediatr. Scand. 1986, 325 (Suppl.): 93-97.
17. Wilton P., Sietnieks A. An open-labelled study of the safety acute metabolic activity and pharmacokinetic profile of a short-term course of recombinant human growth hormone in healthy volunteers. Clin. Endocrinol. (Oxf.) 1987, 26: 125-128.
18. Usala A.L, Blumer J.L. Pharmacology of new hormonal therapies in the treatment of paediatric endocrine disorders. Pediatr. Clin. North Am. 1989, 36: 1157-1182.
19. Moore J.A., Rudman C.G., McLachlan N.J., Fuller G.B., Burnett B., Frane J.W. Equivalent potency and pharmacokinetics of recombinant human growth hormones with or without an N-terminal methionine. Endocrinology 1988, 122: 2920-2926.
20. Levin P., Chalew S., Martin L., Kowarski A. Comparison of assays for growth hormone using monoclonal or polyclonal antibodies for diagnosis of growth disorders. J. Lab. Clin. Med. 1987, 109: 85-88.
21. Woodhead S., Turner G. Accuracy of growth hormone measurements. Horm. Res. 1991, 36 (Suppl.): 17-20.
22. Albertsson-Wikland K. The effect of human growth hormone injection frequency on linear growth rates. Acta Paediatr. Scand. 1987, 337 (Suppl.): 110-116.
23. Jorgensen J.O.L., Moller N., Lauritzen T., Christiansen J.S. The absorption kinetics of subcutaneously administered growth hormone: influence of injection volume. J. Pediatr. Endocrinol. 1989, 3: 213-215.
24. Christiansen J.S., Orskov H., Binder C., Kastrup K.W. Imitation of normal plasma growth hormone profile by subcutaneous administration of human growth hormone to growth hormone deficient children. Acta Endocrinol. (Copenh.) 1983, 102: 6-10.
25. Houdijik E.C.A.M., Herdes E., Delemarre-Van de Waal H.A. Pharmacokinetics and pharmacodynamics of recombinant human growth hormone by subcutaneous jet- or needle-injection in patients with growth hormone deficiency. Acta Paediatr. 1997, 86: 1301-1307.
26. Baumann G. Heterogeneity of growth hormone. In: Bercu B.B., (ed.) Basic and clinical aspects of growth hormone. Plenum Press, New York, 1988, pp. 13-31.